{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:25:05Z","timestamp":1789781105284,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100015217","name":"Veloxis Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015217","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/ajt.12955","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T12:15:31Z","timestamp":1412252131000},"page":"2796-2806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Novel Once-Daily Extended-Release Tacrolimus (LCPT) Versus Twice-Daily Tacrolimus in De Novo Kidney Transplants: One-Year Results of Phase III, Double-Blind, Randomized Trial"],"prefix":"10.1016","volume":"14","author":[{"given":"K.","family":"Budde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bunnapradist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Grinyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ciechanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12955_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003961.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.12955_bib2","series-title":"(OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN\/SRTR 2012 Annual Data Report.","year":"2014"},{"issue":"Suppl 3","key":"10.1111\/ajt.12955_bib3","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib4","unstructured":"Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM181006.pdf. Accessed February 2, 2014."},{"key":"10.1111\/ajt.12955_bib5","series-title":"Prograf Prescribing Information.","year":"2013"},{"key":"10.1111\/ajt.12955_bib6","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12955_bib7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.1990.00390200073014","article-title":"The effect of prescribed daily dose frequency on patient medication compliance","volume":"150","author":"Eisen","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1111\/ajt.12955_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1111\/ajt.12955_bib9","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases","volume":"15","author":"Saini","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1111\/ajt.12955_bib10","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.transproceed.2005.03.017","article-title":"Factors contributing to acute rejection in renal transplantation: The role of noncompliance","volume":"37","author":"Morrissey","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12955_bib11","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/S0041-1345(99)00657-0","article-title":"Kidney graft failure due to noncompliance","volume":"31","author":"Michelon","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12955_bib12","unstructured":"Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070246.pdf. Accessed February 2, 2014."},{"key":"10.1111\/ajt.12955_bib13","unstructured":"MeltDose\u00ae Technology by the US Patent and Trademark Office, US Patent No. 7,217, 431."},{"issue":"Suppl 5","key":"10.1111\/ajt.12955_bib14","first-page":"339","article-title":"Improved bioavailability of MELTDOSE once-daily formulation of tacrolimus (LCP-Tacro) with controlled agglomeration allows for consistent absorption over 24 hrs: A scintigraphic and pharmacokinetic evaluation","volume":"13","author":"Nigro","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib15","unstructured":"Nigro V, Glicklich A, Weinberg J. Flexible dosing of once-daily LCP-Tacro tablets: Morning vs. evening randomized crossover chronopharmacokinetic study. Paper presented at the AST\/ESOT Joint Meeting, Oct. 12\u201314, 2012, Nice, France."},{"issue":"Suppl 2","key":"10.1111\/ajt.12955_bib16","first-page":"355","article-title":"A phase 2 randomized study of the pharmacokinetics, safety and efficacy of LCP-Tacro tablets once-a-day vs Prograf capsules twice-a-day in de novo kidney transplants","volume":"11","author":"Alloway","year":"2011","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1111\/ajt.12955_bib17","first-page":"414","article-title":"A phase 2b, open-label, multi-center, prospective, randomized study to compare the pharmacokinetics and safety of LCP-Tacro\u2122 tablets once-a-day to Prograf\u00ae capsules twice-a-day in de novo kidney transplant patients","volume":"9","author":"Alloway","year":"2009","journal-title":"Am J Transplant"},{"issue":"Suppl 7","key":"10.1111\/ajt.12955_bib18","first-page":"S134","article-title":"A phase 2b, open-label, multicenter, prospective, randomized study to compare the pharmacokinetics and safety of LCP-Tacro\u2122 tablets once-a-day to Prograf\u00ae capsules twice-a-day in de novo liver transplant patients","volume":"15","author":"DuBay","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12955_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/lt.23844","article-title":"Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): Phase II trial of stable liver transplant recipients","volume":"20","author":"Alloway","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12955_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ajt.12035","article-title":"Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): The phase III randomized MELT trial","volume":"13","author":"Bunnapradist","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib21","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/j.1600-6143.2009.02794.x","article-title":"Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: A randomized, open-label trial","volume":"9","author":"Wlodarczyk","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib22","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: A randomized phase III study","volume":"10","author":"Kr\u00e4mer","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-6143.2007.01661.x","article-title":"One-year results with extended-release tacrolimus\/MMF, tacrolimus\/MMF and cyclosporine\/MMF in de novo kidney transplant recipients","volume":"7","author":"Silva","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12955_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1557(199901\/02)8:1<1::AID-PDS382>3.0.CO;2-4","article-title":"Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents","volume":"8","author":"Feldman","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/ajt.12955_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.transproceed.2010.09.103","article-title":"Nonadherent behaviors after solid organ transplantation","volume":"43","author":"Germani","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12955_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00003495-200262040-00002","article-title":"Issues of adherence to immunosuppressant therapy after solid-organ transplantation","volume":"62","author":"Chisholm","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/ajt.12955_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0163-8343(00)00098-0","article-title":"Noncompliance in organ transplant recipients: A literature review","volume":"22","author":"Laederach-Hofmann","year":"2000","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/ajt.12955_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12955","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.12955","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.12955","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.12955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:06:01Z","timestamp":1761627961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522257025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1600613522257025"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12955","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Once-Daily Extended-Release Tacrolimus (LCPT) Versus Twice-Daily Tacrolimus in De Novo Kidney Transplants: One-Year Results of Phase III, Double-Blind, Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}